EMERALD ADVISERS, LLC Portfolio

Auto-discovered 13F filer (Top-2000 by latest reported value).

SEC 13F CIK: 0001015083

What is a 13F filing? Who files one and when · What 13F filings can't tell you

MidDiversifiedHigh Turnover how tags are computed

Q4 2024 · 254 positions · Total reported value $2.58B · Top-10 concentration 22.3% · Updated 2026-10-18

Last updated: 2026-10-18 · Source: SEC EDGAR Form 13F-HR

Turnover: 51.0% · 14 new · 86 cut · 28 exited

Active Share (vs S&P 500): 97.9% · vs QQQ: 98.3% — share of the book that differs from index weights (higher = more active) · ranking

Est. Qtr Return (Q2 2026 → Q3 2026): -14.5% · vs SPY -16.6% · Prev Value $4.25B — last quarter positions weighted by this quarter price moves · ranking

Est. QTD Return (Q3 2026 → newest close): -4.4% · vs SPY -6.6% · Latest Value $3.63B — latest reported positions valued at quarter-to-date price moves (still in progress) · ranking

In its Q4 2024 13F filing, EMERALD ADVISERS, LLC disclosed 254 equity positions with a combined reported value of $2.58B. The filing implies a diversified portfolio: its ten largest positions account for 22.3% of reported value. HoldingsHub classifies the profile as Mid / Diversified / High Turnover.

The largest disclosed positions as of Q4 2024 were CRDO ($92.54M), FTAI ($89.63M), FRPT ($73.76M). By sector, the heaviest allocations are Technology 21.1%, Health Care 19.6%. Versus the prior quarter, allocation shifted toward Consumer Discretionary (+1.8pp), Technology (+0.6pp) and away from Other (-1.5pp), Industrials (-1.9pp).

Versus the prior quarter, EMERALD ADVISERS, LLC opened 14 new positions, trimmed 86 and fully exited 28, a turnover rate of 51.0% of positions. The portfolio's overlap with the prior quarter was 79% of names.

The largest new positions opened in Q4 2024 were ALGT ($22.26M), BOOT ($19.99M), SEI ($19.93M).

Of the 28 positions fully exited versus the prior quarter, the largest were LBPH ($22.79M), CDMO ($16.49M), CLDX ($15.51M).

Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.

New Positions (Q4 2024)

  • ALGT ALLEGIANT TRAVEL CO · $22.26M
  • BOOT BOOT BARN HLDGS INC · $19.99M
  • SEI SOLARIS ENERGY INFRAS INC · $19.93M
  • SITM SITIME CORP · $18.67M
  • TBBK BANCORP INC DEL · $17.69M
  • NVCR NOVOCURE LTD · $16.32M
  • BHVN BIOHAVEN LTD · $13.47M
  • UEC URANIUM ENERGY CORP · $11.11M

Fully Exited (vs previous quarter)

  • LBPH LONGBOARD PHARMACEUTICALS IN · prev qtr: $22.79M
  • CDMO AVID BIOSERVICES INC · prev qtr: $16.49M
  • CLDX CELLDEX THERAPEUTICS INC NEW · prev qtr: $15.51M
  • ONTO ONTO INNOVATION INC · prev qtr: $14.78M
  • EVER EVERQUOTE INC · prev qtr: $13.50M
  • YOU CLEAR SECURE INC · prev qtr: $9.69M
  • SNCY SUN CTRY AIRLS HLDGS INC · prev qtr: $7.91M
  • BIOA BIOAGE LABS INC · prev qtr: $5.85M

Insider Transactions (Form 4)

Latest EMERALD ADVISERS, LLC buys and sells reported on SEC Form 4 — filed within two business days when the fund's ownership in a stock crosses 10%.

No Form 4 filings for this fund yet — when its ownership in a stock crosses 10%, buys and sells are filed here within two business days.

Fund Profile

Emerald Advisers is an SEC-registered 13F filer based in Leola, PA, United States. As of Q2 2026 it reported 237 US equity positions with a combined value of $4.25B. HoldingsHub carries 12 quarters of its filings (Q3 2023–Q2 2026).

Firm Snapshot

  • Headquarters: LEOLA, PA, United States
  • SEC registration: 801-40263 (status: Approved), registered 1991-11-25
  • Regulatory AUM (Form ADV): $3.30B as of 2026-03-31
  • Client mix (by RAUM): pension and profit-sharing plans 100%
  • Website: teamemerald.com

Portfolio Structure

  • 237 positions · $4.25B reported value (Q2 2026)
  • Top 10 holdings = 17.4% of reported value
  • Largest position: TVTX (TRAVERE THERAPEUTICS INC) at 2.1%
  • Average position size: $17.93M

Sector Tilt

  • Information Technology 26.5%
  • Health Care 21.7%
  • Consumer Discretionary 19.5%
  • (classified holdings cover 99% of value)

Quarterly Activity

  • Q2 2026: 28 new, 76 added, 81 reduced, 39 exited
  • 52 positions unchanged

Generated from the firm's public SEC Form 13F and ADV filings. It states what the firm has reported — not an evaluation of its strategy, and not investment advice.

Sector Allocation

Technology 21.1%
Health Care 19.6%
Financials 12.2%
Industrials 11.8%
Other 14.2%
Sort by: Value Shares Weight Sector Change · CSV
# Shares Value Weight Allocation Change
1 1.38M $92.54M 3.58%
3.58%
Reduce
2 622.27K $89.63M 3.47%
3.47%
Reduce
3 498.03K $73.76M 2.86%
2.86%
Reduce
4 484.31K $48.75M 1.89%
1.89%
Reduce
5 249.44K $47.60M 1.84%
1.84%
Reduce
6 684.64K $47.27M 1.83%
1.83%
Reduce
7 435.04K $45.94M 1.78%
1.78%
Reduce
8 657.19K $45.90M 1.78%
1.78%
Reduce
9 1.62M $42.73M 1.66%
1.66%
Reduce
10 823.40K $41.61M 1.61%
1.61%
Reduce
11 925.54K $41.12M 1.59%
1.59%
Reduce
12 3.16M $39.12M 1.51%
1.51%
Add
13 2.13M $37.03M 1.43%
1.43%
Add
14 215.86K $36.63M 1.42%
1.42%
Reduce
15 438.07K $36.59M 1.42%
1.42%
Reduce
16 416.87K $36.36M 1.41%
1.41%
Add
17 425.08K $35.69M 1.38%
1.38%
Add
18 752.54K $34.85M 1.35%
1.35%
Add
19 867.07K $33.61M 1.30%
1.30%
Reduce
20 479.12K $33.47M 1.30%
1.30%
Reduce
21 602.04K $33.14M 1.28%
1.28%
Reduce
22 214.01K $32.93M 1.28%
1.28%
Reduce
23 864.32K $32.58M 1.26%
1.26%
Add
24 313.85K $32.57M 1.26%
1.26%
Reduce
25 1.15M $31.58M 1.22%
1.22%
Add
26 426.99K $31.55M 1.22%
1.22%
Reduce
27 161.80K $31.34M 1.21%
1.21%
Reduce
28 234.01K $30.82M 1.19%
1.19%
Reduce
29 261.84K $30.35M 1.18%
1.18%
Reduce
30 490.16K $30.04M 1.16%
1.16%
Hold
31 302.75K $29.28M 1.13%
1.13%
Reduce
32 543.83K $28.75M 1.11%
1.11%
Reduce
33 254.82K $27.96M 1.08%
1.08%
Reduce
34 123.00K $27.05M 1.05%
1.05%
Add
35 1.07M $26.54M 1.03%
1.03%
Add
36 580.92K $26.11M 1.01%
1.01%
Add
37 588.74K $25.90M 1.00%
1.00%
Reduce
38 1.56M $25.67M 0.99%
0.99%
Reduce
39 924.35K $25.03M 0.97%
0.97%
Add
40 239.44K $24.79M 0.96%
0.96%
Reduce
41 615.93K $24.26M 0.94%
0.94%
Reduce
42 180.29K $23.42M 0.91%
0.91%
Reduce
43 811.68K $23.25M 0.90%
0.90%
Reduce
44 371.71K $23.18M 0.90%
0.90%
Add
45 1.17M $22.58M 0.88%
0.88%
Reduce
46 607.00K $22.37M 0.87%
0.87%
Add
47 236.46K $22.26M 0.86%
0.86%
New
48 518.33K $21.81M 0.84%
0.84%
Reduce
49 1.15M $21.60M 0.84%
0.84%
Reduce
50 583.83K $20.51M 0.80%
0.80%
Add

FAQ

What did EMERALD ADVISERS, LLC buy in 2024-Q4?

In its 2024-Q4 13F filing, EMERALD ADVISERS, LLC reported 254 equity positions worth $2.58B in aggregate; its largest disclosed positions were CRDO ($92.54M), FTAI ($89.63M), FRPT ($73.76M).

How large is EMERALD ADVISERS, LLC's portfolio?

EMERALD ADVISERS, LLC reported $2.58B of long equity holdings across 254 positions as of 2024-Q4. Top-10 holdings account for 22.3% of reported value.

What is EMERALD ADVISERS, LLC's investment style?

HoldingsHub classifies the portfolio as Mid / Diversified / High Turnover, computed from size, concentration, sector tilt and turnover.

Where does this data come from?

All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.

Embed this fund on your site

Copy the snippet below to show this fund's live top holdings on your blog or forum — free, auto-updating, links back to HoldingsHub.

<iframe src="https://holdingshub.top/funds/emerald-advisers/widget" width="100%" height="520" frameborder="0" loading="lazy" title="HoldingsHub fund holdings"></iframe>

Preview the embeddable widget →